Key Takeaways DOCS' Q1 revenues rose 15% to $145.9M with adjusted EBITDA margin of 55%.DOCS' Scribe has 10,000 beta testers, with 75% using the AI note-taking tool weekly.DOCS' $26M Pathway deal adds clinical AI depth, boosting accuracy and physician trust.Doximity (DOCS) entered fiscal 2026 with stronger-than-expected results, reporting first-quarter revenues of $145.9 million (up 15% year over year) and an adjusted EBITDA margin of 55%. But the spotlight of the quarter wasn’t just financial outperformance ...

US MBA mortgage applications fell -12.7% in the week ended September 26, with the purchase mortgage sub-index down -1.0% and the refinancing sub-index down -20.6%. The average 30-year fixed rate mortgage rose +12 bp to 6.46% from 6.34% in the prior week.Stocks initially moved lower on Wednesday due to the US government shutdown, following lawmakers' failure to pass a continuing resolution to fund the government. The dollar index fell to a one-week low on Wednesday, and gold prices climbed to a record high a ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Doximity, Inc. is one of them. Doximity, Inc. (NYSE:DOCS) remains a leading healthcare technology stock, leveraging AI-driven tools and strategic acquisitions to strengthen its position in the medical sector. The company operates a cloud-based professional network for U.S. clinicians, offering secure telemedicine, collaboration, and workflow solutions. Recently, DOCS completed the acquisition of Pathway Medical, an ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: Baird upgraded United Rentals (URI) to Outperform from Neutral with a price target of $1,050, up from $888. The firm says multiple fundamental datapoints suggest stabilization in the broader rental industry following two years of deceleration.Jefferies upgraded Sunrun (RUN) to Buy from Hold with a price target of ...

In this article, we will be taking a look at the 12 Best Healthcare stocks to Buy and Hold for 5 Years.The CEO and co-founder of Claimable, Dr. Warris Bokhari, spoke on CNBC’s “Squawk Box” on July 21 about using AI to challenge health insurance denials and other topics.Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after contacting carriers via phone and email. This can be changed by Dr. Bokhari’s platform, which employs artificial intel ...

公司业务模式 - Hims & Hers Health Inc (HIMS) 运营以消费者为先的平台 提供基于订阅的许可医疗服务 个性化治疗方案以及处方和非处方产品 涵盖性健康 心理健康 皮肤科和减肥领域 [1] - Doximity Inc (DOCS) 作为美国医疗专业人员领先数字网络 拥有超过200万会员 提供以医生为中心的工具 简化工作流程 通过Dialer产品支持远程医疗 并驱动AI驱动的管理效率 [1] - HIMS专注于可负担性和消费者健康接入 而DOCS利用其医生网络和企业解决方案 [2] 股票表现与估值 - 过去三个月HIMS上涨11.1% 表现不及DOCS的21.8%涨幅 但过去一年HIMS飙升208.8% 远超DOCS的73.4%涨幅 [3][6] - HIMS远期市销率(P/S)为4.6倍 高于其三年中位数2.5倍 DOCS远期销售倍数为20.9倍 高于其三年中位数12.6倍 [5] - 两家公司估值均高于医疗行业平均的2.2倍 但HIMS相对较便宜 HIMS增长风格得分为A DOCS为B级 [5] 增长驱动因素 - HIMS - 公司积极多元化产品组合 从性健康和皮肤科核心领域扩展到减肥 睾酮和其他慢性病领域 仿制semaglutide的推出为快速增长的肥胖治疗市场提供重要机会 [7] - 国际扩张加速 通过收购ZAVA加强欧洲业务 并计划2026年进入加拿大 这些举措扩大了总可寻址市场 [7] - 大力投资AI技术 增强诊断能力 个性化治疗方案并简化护理接入 任命Mo Elshenawy显示其成为技术驱动医疗平台的承诺 [8] - 完成8.7亿美元可转换票据发行 为全球扩张 针对性收购和技术开发(包括AI和高级诊断)提供资金支持 [9] 增长驱动因素 - DOCS - 巩固作为美国医疗专业人员领先数字平台地位 超过80%医生活跃在其网络上 参与度创历史新高 超过100万处方医生使用新闻推送 63万处方医生使用工作流工具如Dialer和调度功能 [10] - AI成为关键增长动力 Doximity Scribe(自动临床笔记记录)获得医生强烈采用 超过75%用户每周返回使用 收购Pathway进一步强化AI套件 带来最先进的医疗数据集和临床参考工具 [11] - 制药和卫生系统客户采用率强劲 不断扩大的商业产品组合和数据驱动客户门户推动向上销售 特别是在SMB客户中 贡献广泛增长 [12] 盈利预测 - Zacks共识预测显示HIMS 2025年每股收益(EPS)较2024年预计改善122.2% [15] - DOCS 2026财年EPS预计较2025财年改善6.3% [17] - HIMS当前季度(2025年9月)EPS共识估计0.38美元 同比增长26.67% 下一季度(2025年12月)估计0.43美元 下一财年(2027年3月)估计1.67美元 [19] 价格目标 - 12位分析师给出的Hims & Hers平均短期目标价为48.67美元 较最后收盘价隐含下跌11.3% [20] - 18位分析师给出的Doximity平均短期目标价为68.83美元 较最后收盘价隐含上涨7.5% [23] 投资建议 - HIMS呈现更稳定和财务稳健的投资机会 具有强劲盈利能力和利润率 以及持续增长的用户参与度 提供资本高效模式 产生大量自由现金流和稳定回报 [24] - DOCS快速增长并扩大临床覆盖范围 提供有前景的医生工作流工具和远程医疗支持 但对于寻求较低执行风险 财务可预测性和经过验证记录的投资人 HIMS是更引人注目的选择 [25] - 估值比率显示两家公司都显得昂贵 但DOCS目前似乎处于溢价交易类别 这为投资者偏好HIMS提供了另一个令人信服的理由 [25]

I’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit economics, reinvestment runway, and management quality—and how those factors translate into long-term free cash flow generation and shareholder value creation. I focus on fundamental research, and I tend to focus on sectors with st ...

Doximity (DOCS) closed the most recent trading day at $73.60, moving +1.28% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.48%. At the same time, the Dow added 0.27%, and the tech-heavy Nasdaq gained 0.94%. The stock of medical social networking site has risen by 12.91% in the past month, leading the Medical sector's gain of 1.09% and the S&P 500's gain of 2.46%.Analysts and investors alike will be keeping a close eye on the performance of Doximity in its upcoming earnin ...

公司评级与目标价调整 - Canaccord Genuity将Doximity Inc目标价从59美元上调至67美元 [1] - 公司维持持有评级 [1] 行业技术趋势 - 大型语言模型环境快速变革正在重塑医疗保健技术行业 [1] - 用户信任度对长期成功至关重要 [1] - 用户采用规模和用户采用率仍然重要 [1] 公司竞争地位 - Doximity在人工智能转型早期阶段可能成为领域赢家 [2] - 当前估值水平下维持持有立场 [2]

财务数据和关键指标变化 - 无相关内容 各条业务线数据和关键指标变化 - 无相关内容 各个市场数据和关键指标变化 - 无相关内容 公司战略和发展方向和行业竞争 - 无相关内容 管理层对经营环境和未来前景的评论 - 无相关内容 其他重要信息 - 公司于2025年7月3日记录日拥有136,497,596股A类普通流通股和50,919,611股B类普通流通股 [5] - 年度股东大会通过三项提案 包括选举Jeff Tangney和Keira Wampler担任一类董事至2028年股东大会 批准Deloitte作为2026财年独立审计师 以及通过2025财年高管薪酬咨询投票 [7][9] - 股东大会达到法定投票权多数要求 构成有效会议法定人数 [5] 问答环节所有提问和回答 - 无相关内容